Cipla Limited

₹1,411As of Sun 8 Nov 2026, 12:00 UTC
NSE:CIPLAHealthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR 10.08%
Div yield 0.92%
ROE 8.33%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.10
PE TTM 39.36
TSR TTM (5.13%)
Mkt cap ₹1.140T
ROIC 10.20%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹1,796
27.30%
330.29%
Hold 10|11|10|10|11
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
14.91
15.91
17.32
17.27
9.99%
8.77%
23.99%
11.28%
Revenue₹B
97.43
96.69
100.2
99.19
4.39%
2.34%
7.78%
5.94%
Peers (US$12.14B)
Cap (US$)
PE
12.72B
28.64x
11.17B
46.83x
Capital
TTM
5Y
10Y
Leveragex
1.068
0.524
0.509
EBIT/Intx
0.444
0.102
0.120
Own earn%
(324.24)
(86.70)
(76.92)
Sh yield%
22.55
69.37
67.27
Owners
Insiders/Inst%
6.72
46.89
Short interest%
1.83
SBC / revenue%
5.83
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
0–8
$1 testx
0.1
Incr. ROIC%
2